Search

In recent years, synthesis and characterization of Ag-based materials has become an active area of research due to its application in medical area for having antimicrobial properties useful for prosthetic replacement. Pure HydroxyAPatite (HAP) and 1.5wt% Ag-doped HydroxyAPatite (AgHAP) were prepared by sol-gel process and characterized. Ca(NO3)2.4H2O was used as source of Ca precursor, P2O5 was used as a source of P precursor, and AgNO3 has been used as a source of Ag precursor. Pellets of HAP and AgHAP were made after precipitates were consolidated, dried in oven, grounded and sintered in a muffle furnace. Functional groups were determined using FTIR, and compound formations were investigated using XRD. Microstructural analysis was done using SEM and AFM. Wettability was studied using OCA in distilled water, and corrosion resistance and impedance analyses were carried out using ECA in Ringer solution. It was observed from AFM and XRD that grain size decreased from 7.05 ?m to 1.25 ?m. Improvement in corrosion resistance was observed in AgHAP. Wettability studies showed that AgHAP is more hydrophilic in comparison with pure HAP. A correlation between microstructures and properties of hydroxyapetites are discussed in this paper.

The repurposing of licenced drugs for use against COVID-19 is one of the most rapid ways to develop new and alternative therapeutic options to manage the ongoing pandemic. Given circa 7817 licenced compounds available from Compounds Australia that can be screened, this paper demonstrates the utility of commercially available ex vivo/3D airway and alveolar tissue models. These models are a closer representation of in vivo studies than in vitro models, but retain the benefits of rapid in vitro screening for drug efficacy. We demonstrate that several existing drugs appear to show anti-SARS-CoV-2 activity against both SARS-CoV-2 Delta and Omicron Variants of Concern in the airway model. In particular, fluvoxamine, as well as aprepitant, everolimus, and sirolimus, has virus reduction efficacy comparable to the current standard of care (remdesivir, molnupiravir, nirmatrelvir). Whilst these results are encouraging, further testing and efficacy studies are required before clinical use can be considered.

SARS-CoV-2 is the cause of the COVID-19 pandemic which has claimed more than 6.5 million lives worldwide, devastating the economy and overwhelming healthcare systems globally. The development of new drug molecules and vaccines has played a critical role in managing the pandemic; however, new variants of concern still pose a significant threat as the current vaccines cannot prevent all infections. This situation calls for the collaboration of biomedical scientists and healthcare workers across the world. Repurposing approved drugs is an effective way of fast-tracking new treatments for recently emerged diseases. To this end, we have assembled and curated a database consisting of 7817 compounds from the Compounds Australia Open Drug collection. We developed a set of eight filters based on indicators of efficacy and safety that were applied sequentially to down-select drugs that showed promise for drug repurposing efforts against SARS-CoV-2. Considerable effort was made to evaluate approximately 14,000 assay data points for SARS-CoV-2 FDA/TGA-approved drugs and provide an average activity score for 3539 compounds. The filtering process identified 12 FDA-approved molecules with established safety profiles that have plausible mechanisms for treating COVID-19 disease. The methodology developed in our study provides a template for prioritising drug candidates that can be repurposed for the safe, efficacious, and cost-effective treatment of COVID-19, long COVID, or any other future disease. We present our database in an easy-to-use interactive interface (CoviRx that was also developed to enable the scientific community to access to the data of over 7000 potential drugs and to implement alternative prioritisation and down-selection strategies.

In recent years, synthesis and characterization of Ag-based materials has become an active area of research due to its application in medical area for having antimicrobial properties useful for prosthetic replacement. Pure HydroxyAPatite (HAP) and 1.5wt% Ag-doped HydroxyAPatite (AgHAP) were prepared by sol-gel process and characterized. Ca(NO3)2.4H2O was used as source of Ca precursor, P2O5 was used as a source of P precursor, and AgNO3 has been used as a source of Ag precursor. Pellets of HAP and AgHAP were made after precipitates were consolidated, dried in oven, grounded and sintered in a muffle furnace. Functional groups were determined using FTIR, and compound formations were investigated using XRD. Microstructural analysis was done using SEM and AFM. Wettability was studied using OCA in distilled water, and corrosion resistance and impedance analyses were carried out using ECA in Ringer solution. It was observed from AFM and XRD that grain size decreased from 7.05 ?m to 1.25 ?m. Improvement in corrosion resistance was observed in AgHAP. Wettability studies showed that AgHAP is more hydrophilic in comparison with pure HAP. A correlation between microstructures and properties of hydroxyapetites are discussed in this paper.